Mirae Asset Venture Investment

Funding rounds backed by Mirae Asset Venture Investment.

Export CSV
Funding disclosed in full
$104.4M
Median round
$22M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
LinqAlpha

Builds AI agents for institutional investors to surface market-moving signals in public markets

$22MSeries AFintechUnited States
15 participantsAtinum InvestmentAVPBetatron Venture GroupEast VenturesGFT VenturesHana VenturesMirae Asset CapitalMirae Asset Venture InvestmentNH Investment & SecuritiesNuVenturesSamsung SecuritiesSBI InvestmentShinhan Venture InvestmentSV InvestmentZ Venture Capital
Crossbow Therapeutics

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

$77MSeries BBiotechUnited States
13 participantsArkin Bio CapitalBlood Cancer United's Therapy Acceleration ProgramBVF PartnersEli Lilly and CompanyHamilton Square PartnersLibbs VenturesLifeLink VenturesMirae Asset Venture InvestmentMPM BioImpactPfizer VenturesPolaris PartnersSixty Degree CapitalTaiho Ventures
Playad

Builds multi-agent AI marketing workflows for creating, testing, and improving advertising creative

$5.4MPre-SeedAIUnited States
5 participantsBora ChungBRV Capital ManagementJihun YuKrew CapitalMirae Asset Venture Investment